Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Phenytoin (diphenylhydantoin)

4

VII.a Lymphadenopathy (intrathoracic)

2
Last update : 22/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Anticonvulsants
3

Publications

Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns.
The American journal of surgical pathology 1995 Jun;19;675-86 1995 Jun
Does prolonged use of diphenylhydantoin predispose to pulmonary sarcoidosis?
European neurology 1986;25;281-4 1986
Necrotizing vasculitis associated with diphenylhydantoin: two fatal cases.
Human pathology 1983 Feb;14;182-4 1983 Feb
Lymphadenopathy associated with diphenylhydantoin therapy.
Clinical oncology 1982 Dec;8;351-6 1982 Dec
[Lymphadenopathies and protein anomalies following phenylhydantoine therapy].
La Nouvelle presse medicale 1976 Apr 24;5;1125-7 1976 Apr 24

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies